Tetrahydroisoquinoline derivatives as melatonin MT2 antagonists
申请人:——
公开号:US20040235891A1
公开(公告)日:2004-11-25
The invention encompasses a series of tetrahydroisoquinolines of formula I which are antagonists of the human melatonin MT
2
receptor and are useful as chronobiotic and sleep agents.
1